ORIENT-12: Sintilimab plus gemcitabine and platinum (GP) as first-line (1L) treatment for locally advanced or metastatic squamous non-small-cell lung cancer (sqNSCLC)-MedSci.cn

ORIENT-12: Sintilimab plus gemcitabine and platinum (GP) as first-line (1L) treatment for locally advanced or metastatic squamous non-small-cell lung cancer (sqNSCLC)

Zhou, C; Wu, L; Fan, Y; Wang, Z; Liu, L; Chen, G; Zhang, L; Huang, D; Cang, S; Yang, Z; Zhou, J; Zhou, C; Li, B; Li, J; Fan, M; Zhang, W; Yang, W; Wang, S; Zhou, H

ANNALS OF ONCOLOGY, 2020; 31 (): S1186

科室
- - 订阅+
  - 更多科室
工具
服务